BILL NUMBER: AB 259	INTRODUCED
	BILL TEXT


INTRODUCED BY   Assembly Member Adams

                        FEBRUARY 5, 2007

   An act to amend Section 11054 of the Health and Safety Code,
relating to controlled substances.


	LEGISLATIVE COUNSEL'S DIGEST


   AB 259, as introduced, Adams. Controlled substances: Schedule I.
   Existing law lists various controlled hallucinogenic substances in
Schedule I.
   This bill would add Salvia Divinorum to that list.
   Because this bill would expand the definition of existing crimes,
it would create a state-mandated local program.
   The California Constitution requires the state to reimburse local
agencies and school districts for certain costs mandated by the
state. Statutory provisions establish procedures for making that
reimbursement.
   This bill would provide that no reimbursement is required by this
act for a specified reason.
   Vote: majority. Appropriation: no. Fiscal committee: yes.
State-mandated local program: yes.


THE PEOPLE OF THE STATE OF CALIFORNIA DO ENACT AS FOLLOWS:

  SECTION 1.  Section 11054 of the Health and Safety Code is amended
to read:
   11054.  (a) The controlled substances listed in this section are
included in Schedule I.
   (b) Opiates. Unless specifically excepted or unless listed in
another schedule, any of the following opiates, including their
isomers, esters, ethers, salts, and salts of isomers, esters, and
ethers whenever the existence of those isomers, esters, ethers, and
salts is possible within the specific chemical designation:
   (1) Acetylmethadol.
   (2) Allylprodine.
   (3) Alphacetylmethadol (except levoalphacetylmethadol, also known
as levo-alpha- acetylmethadol, levomethadyl acetate, or LAAM).
   (4) Alphameprodine.
   (5) Alphamethadol.
   (6) Benzethidine.
   (7) Betacetylmethadol.
   (8) Betameprodine.
   (9) Betamethadol.
   (10) Betaprodine.
   (11) Clonitazene.
   (12) Dextromoramide.
   (13) Diampromide.
   (14) Diethylthiambutene.
   (15) Difenoxin.
   (16) Dimenoxadol.
   (17) Dimepheptanol.
   (18) Dimethylthiambutene.
   (19) Dioxaphetyl butyrate.
   (20) Dipipanone.
   (21) Ethylmethylthiambutene.
   (22) Etonitazene.
   (23) Etoxeridine.
   (24) Furethidine.
   (25) Hydroxypethidine.
   (26) Ketobemidone.
   (27) Levomoramide.
   (28) Levophenacylmorphan.
   (29) Morpheridine.
   (30) Noracymethadol.
   (31) Norlevorphanol.
   (32) Normethadone.
   (33) Norpipanone.
   (34) Phenadoxone.
   (35) Phenampromide.
   (36) Phenomorphan.
   (37) Phenoperidine.
   (38) Piritramide.
   (39) Proheptazine.
   (40) Properidine.
   (41) Propiram.
   (42) Racemoramide.
   (43) Tilidine.
   (44) Trimeperidine.
   (45) Any substance which contains any quantity of acetylfentanyl
(N-(1-phenethyl-4-piperidinyl) acetanilide) or a derivative thereof.
   (46) Any substance which contains any quantity of the thiophene
analog of acetylfentanyl (N-(1-(2-(2-thienyl)ethyl)-4-piperidinyl)
acetanilide) or a derivative thereof.
   (47) 1-Methyl-4-Phenyl-4-Propionoxypiperidine (MPPP).
   (48) 1-(2-Phenethyl)-4-Phenyl-4-Acetyloxypiperidine (PEPAP).
   (c)  Opium derivatives. Unless specifically excepted or unless
listed in another schedule, any of the following opium derivatives,
its salts, isomers, and salts of isomers whenever the existence of
those salts, isomers, and salts of isomers is possible within the
specific chemical designation:
   (1) Acetorphine.
   (2) Acetyldihydrocodeine.
   (3) Benzylmorphine.
   (4) Codeine methylbromide.
   (5) Codeine-N-Oxide.
   (6) Cyprenorphine.
   (7) Desomorphine.
   (8) Dihydromorphine.
   (9) Drotebanol.
   (10) Etorphine (except hydrochloride salt).
   (11) Heroin.
   (12) Hydromorphinol.
   (13) Methyldesorphine.
   (14) Methyldihydromorphine.
   (15) Morphine methylbromide.
   (16) Morphine methylsulfonate.
   (17) Morphine-N-Oxide.
   (18) Myrophine.
   (19) Nicocodeine.
   (20) Nicomorphine.
   (21) Normorphine.
   (22) Pholcodine.
   (23) Thebacon.
   (d) Hallucinogenic substances. Unless specifically excepted or
unless listed in another schedule, any material, compound, mixture,
or preparation, which contains any quantity of the following
hallucinogenic substances, or which contains any of its salts,
isomers, and salts of isomers whenever the existence of those salts,
isomers, and salts of isomers is possible within the specific
chemical designation (for purposes of this subdivision only, the term
"isomer" includes the optical, position, and geometric isomers):
   (1) 4-bromo-2,5-dimethoxy-amphetamine--Some trade or other names:
4-bromo-2,5-dimethoxy-alpha-methylphenethylamine; 4-bromo-2,5-DMA.
   (2) 2,5-dimethoxyamphetamine--Some trade or other names:
2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA.
   (3) 4-methoxyamphetamine--Some trade or other names:
4-methoxy-alpha-methylphenethylamine, paramethoxyamphetamine, PMA.
   (4) 5-methoxy-3,4-methylenedioxy-amphetamine.
   (5) 4-methyl-2,5-dimethoxy-amphetamine--Some trade or other names:
4-methyl-2,5-dimethoxy-alpha-methylphenethylamine; "DOM"; and "STP."

   (6) 3,4-methylenedioxy amphetamine.
   (7) 3,4,5-trimethoxy amphetamine.
   (8) Bufotenine--Some trade or other names: 3-
(beta-dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5
indolol; N,N-dimethylserolonin, 5-hydroxy-N,N-dimethyltryptamine;
mappine.
   (9) Diethyltryptamine--Some trade or other names:
N,N-Diethyltryptamine; DET.
   (10) Dimethyltryptamine--Some trade or other names: DMT.
   (11) Ibogaine--Some trade or other names: 7-Ethyl-6,6beta,
7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido (1',2':1,2)
azepino (5,4-b) indole; Tabernantheiboga.
   (12) Lysergic acid diethylamide.
   (13) Marijuana.
   (14) Mescaline.
   (15) Peyote--Meaning all parts of the plant presently classified
botanically as Lophophora williamsii Lemaire, whether growing or not,
the seeds thereof, any extract from any part of the plant, and every
compound, manufacture, salts, derivative, mixture, or preparation of
the plant, its seeds or extracts (interprets 21 U.S.C. Sec. 812(c),
Schedule 1(c)(12)).
   (16) N-ethyl-3-piperidyl benzilate.
   (17) N-methyl-3-piperidyl benzilate.
   (18) Psilocybin.
   (19) Psilocyn. 
   (20) Salvia Divinorum  
   (20) 
    (21)  Tetrahydrocannabinols. Synthetic equivalents of
the substances contained in the plant, or in the resinous extractives
of Cannabis, sp. and/or synthetic substances, derivatives, and their
isomers with similar chemical structure and pharmacological activity
such as the following: delta 1 cis or trans tetrahydrocannabinol,
and their optical isomers; delta 6 cis or trans tetrahydrocannabinol,
and their optical isomers; delta 3,4 cis or trans
tetrahydrocannabinol, and its optical isomers.
   (Since nomenclature of these substances is not internationally
standardized, compounds of these structures, regardless of numerical
designation of atomic positions covered). 
   (21) 
    (22)  Ethylamine analog of phencyclidine--Some trade or
other names: N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl)
ethylamine, N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE.

   (22) 
    (23)  Pyrrolidine analog of phencyclidine--Some trade or
other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCP, PHP. 
   (23) 
    (24)  Thiophene analog of phencyclidine--Some trade or
other names: 1-(1-(2 thienyl)-cyclohexyl)-piperidine, 2-thienyl
analog of phencyclidine, TPCP, TCP.
   (e)  Depressants. Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or preparation
which contains any quantity of the following substances having a
depressant effect on the central nervous system, including its salts,
isomers, and salts of isomers whenever the existence of those salts,
isomers, and salts of isomers is possible within the specific
chemical designation:
   (1) Mecloqualone.
   (2) Methaqualone.
   (3) Gamma hydroxybutyric acid (also known by other names such as
GHB; gamma hydroxy butyrate; 4-hydroxybutyrate; 4-hydroxybutanoic
acid; sodium oxybate; sodium oxybutyrate), including its immediate
precursors, isomers, esters, ethers, salts, and salts of isomers,
esters, and ethers, including, but not limited to,
gammabutyrolactone, for which an application has not been approved
under Section 505 of the Federal Food, Drug, and Cosmetic Act (21
U.S.C. Sec. 355).
   (f) Unless specifically excepted or unless listed in another
schedule, any material, compound, mixture, or preparation which
contains any quantity of the following substances having a stimulant
effect on the central nervous system, including its isomers:
   (1) Cocaine base.
   (2) Fenethylline, including its salts.
   (3) N-Ethylamphetamine, including its salts.
  SEC. 2.  No reimbursement is required by this act pursuant to
Section 6 of Article XIII B of the California Constitution because
the only costs that may be incurred by a local agency or school
district will be incurred because this act creates a new crime or
infraction, eliminates a crime or infraction, or changes the penalty
for a crime or infraction, within the meaning of Section 17556 of the
Government Code, or changes the definition of a crime within the
meaning of Section 6 of Article XIII B of the California
Constitution.